Liver Panel Clinical Trials

• Study of a Long-Term Combination of Mycophenolate Mofetil and Sirolimus in Patients Who Received a Liver Transplant
  ClinicalTrials.gov Identifier: NCT00118742 - Active, not recruiting
  Liver Diseases; Liver Transplantation
  
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  ClinicalTrials.gov Identifier: NCT00003907 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
  ClinicalTrials.gov Identifier: NCT00163657 - Active, not recruiting
  Liver Transplantation
  
• A Study of Thymoglobulin and Tacrolimus in Liver Transplant
  ClinicalTrials.gov Identifier: NCT00564538 - Enrolling by invitation
  Liver Transplantation; Liver Disease; Immunosuppression
  
• Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004136 - Active, not recruiting
  recurrent adult primary liver cancer; stage III childhood liver cancer; liver metastases; advanced adult primary liver cancer; ...
  
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00040898 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization
  ClinicalTrials.gov Identifier: NCT00005667 - Active, not recruiting
  Liver Diseases
  
• DX-8951f in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004108 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003530 - Active, not recruiting
  stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients with Primary Liver Cancer for Whom Surgery is Not Possible.
  ClinicalTrials.gov Identifier: NCT00152087 - Recruiting
  Liver Cancer
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00019786 - Active, not recruiting
  Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
  
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003994 - Active, not recruiting
  stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
  
• Steroid Free Immunosuppression in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00296244 - Recruiting
  Liver Cirrhosis; Liver Transplant Recipients
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• A Phase II Study of DMP 115 to Assess Focal Liver Lesions
  ClinicalTrials.gov Identifier: NCT00162058 - Active, not recruiting
  Liver Disease
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Oxaliplatin in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00052364 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00006010 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00083226 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00450398 - Active, not recruiting
  Liver Diseases
  
• Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00238901 - Active, not recruiting
  Liver Transplant
  
• Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver
  ClinicalTrials.gov Identifier: NCT00290316 - Active, not recruiting
  Hepatocellular Carcinoma; Hepatoma; Cholangiocarcinoma; Liver Metastases
  
• Evaluation of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00086346 - Active, not recruiting
  Liver Transplantation; Hepatic Transplantation
  
• Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant
  ClinicalTrials.gov Identifier: NCT00063648 - Active, not recruiting
  Liver Disease; Lymphoproliferative Disorders
  
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003714 - Active, not recruiting
  advanced adult primary liver cancer; liver metastases; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00282256 - Active, not recruiting
  Liver Transplantation
  
• Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)
  ClinicalTrials.gov Identifier: NCT00488917 - Recruiting
  Liver Diseases; Liver Cirrhosis; Sepsis; Critical Illness
  
• Total Parenteral Nutrition-Associated Liver Disease
  ClinicalTrials.gov Identifier: NCT00031135 - Recruiting
  Liver Diseases
  
• A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00282243 - Active, not recruiting
  Liver Transplantation
  
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus with Standard Treatment
  ClinicalTrials.gov Identifier: NCT00006164 - Active, not recruiting
  Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
  
• Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00326482 - Recruiting
  Liver Fibrosis
  
• A Study to Evaluate the Effect of Thymoglobulin Induction Therapy and Reduced Doses of Calcineurin Inhibitors On the Incidence of Liver Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00117689 - Active, not recruiting
  Liver Diseases; Transplant Rejection
  
• Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer.
  ClinicalTrials.gov Identifier: NCT00151671 - Recruiting
  Liver Cancer; Hepatocellular Carcinoma; Cirrhosis; Liver Fibrosis
  
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109954 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00206076 - Recruiting
  Liver Transplantation; Liver Disease; Graft Rejection
  
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077142 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077441 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
  ClinicalTrials.gov Identifier: NCT00049842 - Active, not recruiting
  Chronic Hepatitis C; Liver Fibrosis
  
• Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00080236 - Active, not recruiting
  Liver Transplantation; Hepatitis; Cholestasis; Carcinoma, Hepatocellular
  
• Efficacy and Safety Assessment of Cyclosporine Microemulsion C2 Monitoring Versus Tacrolimus C0 Monitoring in De Novo Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00149994 - Active, not recruiting
  Liver transplant
  
• Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00026234 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00071994 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00189826 - Active, not recruiting
  Liver Transplantation
  
• Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00295594 - Active, not recruiting
  Liver Transplantation
  
• Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00171509 - Active, not recruiting
  Liver Transplant
  
• Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00171743 - Active, not recruiting
  Liver Transplant
  
• Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00469963 - Active, not recruiting
  Liver Cancer
  
• Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
  ClinicalTrials.gov Identifier: NCT00402402 - Recruiting
  Chronic Liver Disease; Liver Transplantation; Tuberculosis
  
• AZD2171 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00238394 - Active, not recruiting
  Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
  
• Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00374231 - Active, not recruiting
  Liver Transplant
  
• Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
  ClinicalTrials.gov Identifier: NCT00063635 - Active, not recruiting
  Fatty Liver
  
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00041275 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in “de Novo” Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00343226 - Active, not recruiting
  Liver Transplantation
  
• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00257426 - Active, not recruiting
  Liver Cancer
  
• Chemotherapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003044 - Active, not recruiting
  localized unresectable adult primary liver cancer
  
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases from Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00008294 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Immunosuppression with Campath-1H and Tacrolimus in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00105235 - Active, not recruiting
  Liver Transplantation
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00295607 - Active, not recruiting
  Hepatitis C; Liver Transplantation
  
• Liver Transplants in People With HIV Infection
  ClinicalTrials.gov Identifier: NCT00473629 - Active, not recruiting
  HIV Infections; Liver Disease
  
• Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong
  ClinicalTrials.gov Identifier: NCT00577044 - Active, not recruiting
  Fatty Liver
  
• Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases(CELIM)
  ClinicalTrials.gov Identifier: NCT00153998 - Recruiting
  Colorectal cancer, liver metastases
  
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004248 - Active, not recruiting
  recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
  ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
  HIV Infections; Hepatitis C; Liver Disease
  
• Enteric Coated Myfortic for Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00167492 - Recruiting
  Liver Transplantation
  
• Celecoxib and Erlotinib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00293436 - Active, not recruiting
  Liver Cancer
  
• Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00302484 - Active, not recruiting
  Osteoporosis; Liver Transplantation
  
• Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00028626 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Liver Perfusion of Melphalan in Inoperable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00001820 - Recruiting
  Liver Neoplasm; Neoplasm Metastasis
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590)
  ClinicalTrials.gov Identifier: NCT00378599 - Recruiting
  Liver Transplantation; Hepatitis C, Chronic; Liver Cirrhosis
  
• Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
  ClinicalTrials.gov Identifier: NCT00004697 - Active, not recruiting
  Fatty Liver
  
• Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
  ClinicalTrials.gov Identifier: NCT00093444 - Active, not recruiting
  Liver Cancer; Metastatic Cancer
  
• T900607 in Treating Patients With Unresectable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00054262 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00492739 - Recruiting
  Liver Disease; Liver Transplantation; Varicella
  
• Metformin in Non-Alcoholic Fatty Liver Disease
  ClinicalTrials.gov Identifier: NCT00303537 - Active, not recruiting
  Fatty Liver
  
• Oxaliplatin and Capecitabine Versus Follow-Up After Resection of Colorectal Liver Metastases
  ClinicalTrials.gov Identifier: NCT00156975 - Active, not recruiting
  Colorectal Neoplasms; Liver Metastases
  
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00009893 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure
  ClinicalTrials.gov Identifier: NCT00470314 - Active, not recruiting
  Acute Liver Failure
  
• Tamoxifen in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003424 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer; Quality of Life
  
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00020774 - Active, not recruiting
  recurrent adult primary liver cancer; localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
  ClinicalTrials.gov Identifier: NCT00510627 - Not yet recruiting
  Metastatic Liver Cancer; Secondary Liver Cancer; Liver Neoplasm
  
• MMF Influence on HCV Viral Evolution After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00170131 - Active, not recruiting
  HCV Infection; Liver Transplantation
  
• An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00247676 - Recruiting
  Liver Neoplasms
  
• Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
  ClinicalTrials.gov Identifier: NCT00247117 - Recruiting
  Liver Diseases
  
• Microarray Analysis of Gene Expression in Liver Tumors
  ClinicalTrials.gov Identifier: NCT00373737 - Recruiting
  Liver Cancer
  
• Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
  ClinicalTrials.gov Identifier: NCT00422877 - Recruiting
  Cancer of the Liver
  
• Transoesophageal Echocardiography in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00547924 - Recruiting
  End Stage Liver Disease
  
• Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique
  ClinicalTrials.gov Identifier: NCT00172705 - Recruiting
  Liver Disease
  
• Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00177931 - Recruiting
  Liver Transplantation
  
• RESCUE Study – Everolimus in Liver Transplant Recipients With Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00267189 - Recruiting
  Liver Transplantation
  
• Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy
  ClinicalTrials.gov Identifier: NCT00378014 - Recruiting
  Liver Transplantation
  
• Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: a Comparative Trial.
  ClinicalTrials.gov Identifier: NCT00436722 - Recruiting
  Liver Diseases
  
• Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
  ClinicalTrials.gov Identifier: NCT00529204 - Not yet recruiting
  Diabetes Complications; Fatty Liver; Lipid Metabolism
  
• Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00030563 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
  ClinicalTrials.gov Identifier: NCT00185874 - Recruiting
  Liver Cancer
  
• Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
  ClinicalTrials.gov Identifier: NCT00263978 - Recruiting
  Liver Diseases
  
• Safety of Withdrawing Immunosuppressive Drugs in Children Who Have Received a Liver Transplant
  ClinicalTrials.gov Identifier: NCT00320606 - Recruiting
  Liver Transplantation; Immunosuppression